AliveCor vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
AliveCor makes FDA-cleared AI-powered portable ECG devices and the KardiaMobile platform for consumer and clinical cardiac monitoring; detects AFib and other arrhythmias; raised $65M+ in funding;
About
AliveCor is a Mountain View, California-based medical device and digital health company founded in 2010 by Dr. David Albert. The company pioneered the consumer cardiac monitoring category with KardiaMobile — a small, FDA-cleared electrocardiogram (ECG) device that attaches to a smartphone and enables users to record medical-grade single-lead ECG traces in 30 seconds. The AI algorithm running on the KardiaMobile platform analyzes each recording for atrial fibrillation (AFib) and other cardiac arrhythmias, delivering immediate results that users can share with their physicians.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.